Showing results (11-20 of 113) with videos related to
Sort By:
Pageof 12
Herz|March 11, 2016
[PCSK9 inhibitors in hypercholesterolemia. New hope for patients with diabetes mellitus?]K G ParhoferMMW Fortschritte Der Medizin|November 9, 2002
[Glinides and glitazones in diabetes treatment. Are they really effective?]K G Parhofer, B GökeExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 19, 2007
Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinologyM Vogeser, K G ParhoferJournal of Internal Medicine|January 5, 2000
Influence of protease inhibitor therapy on lipoprotein metabolismH K Berthold, K G Parhofer, M M Ritter, et al.Metabolism: Clinical and Experimental|April 29, 1998
Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kineticsP H Barrett, K G ParhoferTherapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|December 9, 2000
Efficacy of different low-density lipoprotein apheresis methodsK G Parhofer, H C Geiss, P SchwandtExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 12, 2002
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemiaH C Geiss, P Schwandt, K G ParhoferAtherosclerosis|June 25, 1999
Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parametersK G Parhofer, P H Barrett, P SchwandtJournal of Internal Medicine|March 30, 1999
Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresisH C Geiss, K G Parhofer, P SchwandtPageof 12